-
1
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Baskı/Yayın Bilgisi 2025Konular: -
2
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Baskı/Yayın Bilgisi 2025Konular: -
3
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Baskı/Yayın Bilgisi 2025Konular: -
4
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Baskı/Yayın Bilgisi 2025Konular: -
5
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Baskı/Yayın Bilgisi 2025Konular: -
6
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Baskı/Yayın Bilgisi 2025Konular: -
7
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Baskı/Yayın Bilgisi 2025Konular: -
8
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Baskı/Yayın Bilgisi 2025Konular: -
9
Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Baskı/Yayın Bilgisi 2025Konular: -
10
Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Baskı/Yayın Bilgisi 2025Konular: -
11
Supplementary Data 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Baskı/Yayın Bilgisi 2025Konular: -
12
Supplementary Data 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Baskı/Yayın Bilgisi 2025Konular: -
13
Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Baskı/Yayın Bilgisi 2025Konular: -
14
Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Baskı/Yayın Bilgisi 2025Konular: